Skip to content
Politically.com Search all
Menu

HR 10770 119th Congress

340B Rebate Model Delay Act

To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program.

Official Title as Introduced Congress.gov

Introduced Oct 9, 2026 Latest action Oct 9, 2026 Sponsor: Rep. Bresnahan, Robert P. [R-PA-8] Health
Open official Congress.gov record
Source: Congress.govUpdated 2026-11-05 00:08:42 UTC.

Source-linked procedural record

Bill journey

5 dated records

This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.

Congress.gov Recently refreshed U.S. Senate XML Latest available (refresh delayed)
Introduction 1 One supplied introduction date.
Official actions 3 3 dated action records.
Committees 1 1 undated relationship.
Amendments 0 No record is cached.
Text versions 1 1 dated, 0 without a supplied date.
House roll calls 0 No exact legislation-key match in the House-vote cache.
Senate roll calls 0 No exact document-key match in the Senate-vote cache.
Related measures 0 No related-measure relationship is cached.
Linked law 0 No linked law record is cached; this does not predict outcome.
  1. Official action Congress.gov

    Referred to the House Committee on Energy and Commerce.

    IntroReferral · House floor actions · Code H11100

    Open bill record

    Official action Congress.gov

    Introduced in House

    IntroReferral · Library of Congress · Code Intro-H

    Open bill record

    Official action Congress.gov

    Introduced in House

    IntroReferral · Library of Congress · Code 1000

    Open bill record

    Text version Congress.gov

    Introduced in House

    A dated text-version record is available.

    Open text record
View the complete bill journey as an accessible table
Every dated cached record linked to HR 10770. Same-date row order does not assert procedural sequence.
Date and timeRecordOfficial detailSource
IntroductionIntroduced Introduced in the House. Congress.gov
Official actionReferred to the House Committee on Energy and Commerce. No additional detail supplied.IntroReferral · House floor actions · Code H11100 Congress.gov
Official actionIntroduced in House No additional detail supplied.IntroReferral · Library of Congress · Code Intro-H Congress.gov
Official actionIntroduced in House No additional detail supplied.IntroReferral · Library of Congress · Code 1000 Congress.gov
Text versionIntroduced in House A dated text-version record is available. Congress.gov

House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.

Congressional Research Service

CRS summary

Introduced in House Oct 9, 2026

340B Rebate Model Delay ActThis bill temporarily limits the use of rebates for prescription drugs under the 340B program and delays the implementation of the 340B Rebate Model Pilot Program.Under current law, the 340B program generally limits the maximum price drug manufacturers participating in Medicaid or Medicare can charge eligible health care organizations for covered outpatient drugs. Beginning on January 1, 2027, and ending on December 31, 2028, the bill prohibits drug manufacturers from entering agreements with 340B organizations that require the organization to pay more than the allowable ceiling price for a covered outpatient drug at the time of purchase and subsequently receive a rebate to comply with the maximum price requirements.The bill also delays until January 1, 2029, the implementation of the 340B Rebate Model Pilot Program. The pilot program allows approved drug manufacturers to charge 340B organizations full price for certain high-impact drugs and provide a rebate that reduces the amount paid to the allowable ceiling price after the drug is dispensed. Under the pilot program, the rebates are verified and issued on a claim-by-claim basis.

Official documents

Text versions